Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-001019

Options or other derivatives

  • President and Head of R&D acquired 790,093 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nagendran Sukumar · President and Head of R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-30 Grant or award : show line 1 in the form Stock Option (right to buy) +790,093 790,093 D
Loading xslF345X03/doc4.xml…